BioSpace News Archive

Automata Technologies, a leading automation company powering life sciences labs, has raised $40m to accelerate its rapid growth and industry presence across the US, UK and EMEA.

The University of Oxford and Harrington Discovery Institute at University Hospitals in Cleveland, Ohio announced the launch of the Oxford-Harrington Rare Disease Centre Therapeutics Accelerator with an official signing event at the University of Oxford.

Copenhagen, Denmark - FluoGuide A/S, a pioneer in the cutting-edge field of precision cancer surgery, is pleased to announce its lead asset FG001 has received Orphan Drug Designation from the U. S. Food and Drug Administration as an optical imaging agent for the visualization of malignant tissue during surgery for high-grade glioma.

Regenative Labs (Regenative), a leading HCT/P manufacturer, announces a retrospective case series demonstrating new care advancements using its Wharton’s Jelly allografts in the supplementation of Temporomandibular Joint (TMJ) defects.

A*STAR’s Genome Institute of Singapore, NanoString® Technologies, Inc., and Next Level Genomics, announced the establishment of a joint laboratory in Singapore focusing on the application of spatial biology to identify biomarkers that can predict disease progression and treatment response.